Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

ESWT versus conventional physical therapy for Greater Trochanteric Pain Syndrome

Official title: A Prospective Randomized Controlled Trial Comparing the Effectiveness of Extracorporeal Shockwave Therapy and Conventional Physical Therapy in Patients With Greater Trochanteric Pain Syndrome

Run by Kanuni Sultan Suleyman Training and Research Hospital · NCT07243327 · Data updated 2026-11-12

This trial will try Extracorporeal Shockwave Therapy (ESWT) against usual physical therapy to see which reduces pain and improves function in adults with Greater Trochanteric Pain Syndrome.

More Greater Trochanteric Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorKanuni Sultan Suleyman Training and Research Hospital
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedMarch 2026
Study endsMarch 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT07243327 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with lateral hip pain for at least 3 months and MRI-confirmed GTPS who can attend clinic visits and follow the exercise program are ideal candidates.

Probably not a fit

Patients with hip tendon tears, recent hip infection or trauma, lumbar radiculopathy or prior lumbar surgery, recent corticosteroid injection to the hip, active systemic inflammatory disease, active malignancy, or cognitive impairment are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 60 adults aged 18–65 with MRI-confirmed Greater Trochanteric Pain Syndrome and allocate them 1:1 to ESWT or conventional physical therapy. The ESWT arm receives five sessions over three weeks (15 Hz, 3 bar, 2000 pulses) while the physical therapy arm receives ten sessions of TENS, hot pack, and continuous ultrasound; both groups follow a standardized exercise program. Outcomes include pain (VAS), hip function (Harris Hip Score), lower extremity function (LEFS), and a Global Rating of Change measured at baseline, week 3, and week 12. The primary aim is to see which treatment produces greater short-term pain relief, with secondary analyses of functional improvement.

Why it matters

Potential benefit: If successful, ESWT could provide faster or greater pain relief and improved hip function than conventional physical therapy for people with GTPS.

How similar studies have gone: Previous randomized trials and case series of ESWT for gluteal tendinopathy have generally shown favorable outcomes compared with sham or conservative care, though results have varied across studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Lateral hip pain for at least 3 months
* Ability to understand study procedures and provide informed consent

Exclusion Criteria:

* Hip deformities
* Gluteus medius, gluteus minimus, or piriformis tendon tears
* Lumbar radiculopathy or history of lumbar spine surgery
* Recent trauma or active infection in the hip region
* Corticosteroid injection to the hip within the last 6 months
* Neurological, psychiatric, or rheumatologic diseases
* Active malignancy or systemic inflammatory disease
* Cognitive impairment preventing cooperation

Where it's running

  • Kanuni Sultan Süleyman Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.